BACKGROUND AND PURPOSE: 5' adenosine monophosphate-dependent protein kinase (AMPK) acts as a metabolic sensor. AMPK is elevated under ischemic conditions, but the role of AMPK in ischemic brain remains controversial. In this study, we examined the effects of AMPK inhibition using both pharmacological and genetic approaches in an in vivo stroke model. METHODS: Focal stroke was induced by reversible middle cerebral artery occlusion in male wild-type mice as well as mice deficient in one of the isoforms of the catalytic subunit of AMPK, AMPK alpha-1 or alpha-2. RESULTS: AMPK inhibition was neuroprotective after focal stroke. Mice deficient in AMPK alpha-2 demonstrated significantly smaller infarct volumes compared with wild-type littermates, whereas deletion of AMPK alpha-1 had no effect. Phosphorylation of a major upstream regulator of AMPK, LKB1, was also induced in stroke brain. CONCLUSIONS: AMPK activation is detrimental in a model of focal stroke. The AMPK catalytic isoform alpha-2 contributes to the deleterious effects of AMPK activation. AMPK inhibition leads to neuroprotection even when these agents are administered poststroke.
BACKGROUND AND PURPOSE: 5' adenosine monophosphate-dependent protein kinase (AMPK) acts as a metabolic sensor. AMPK is elevated under ischemic conditions, but the role of AMPK in ischemic brain remains controversial. In this study, we examined the effects of AMPK inhibition using both pharmacological and genetic approaches in an in vivo stroke model. METHODS: Focal stroke was induced by reversible middle cerebral artery occlusion in male wild-type mice as well as mice deficient in one of the isoforms of the catalytic subunit of AMPK, AMPK alpha-1 or alpha-2. RESULTS: AMPK inhibition was neuroprotective after focal stroke. Mice deficient in AMPK alpha-2 demonstrated significantly smaller infarct volumes compared with wild-type littermates, whereas deletion of AMPK alpha-1 had no effect. Phosphorylation of a major upstream regulator of AMPK, LKB1, was also induced in stroke brain. CONCLUSIONS: AMPK activation is detrimental in a model of focal stroke. The AMPK catalytic isoform alpha-2 contributes to the deleterious effects of AMPK activation. AMPK inhibition leads to neuroprotection even when these agents are administered poststroke.
Authors: Sebastian B Jørgensen; Benoit Viollet; Fabrizio Andreelli; Christian Frøsig; Jesper B Birk; Peter Schjerling; Sophie Vaulont; Erik A Richter; Jørgen F P Wojtaszewski Journal: J Biol Chem Date: 2003-10-21 Impact factor: 5.157
Authors: B Viollet; F Andreelli; S B Jørgensen; C Perrin; D Flamez; J Mu; J F P Wojtaszewski; F C Schuit; M Birnbaum; E Richter; R Burcelin; S Vaulont Journal: Biochem Soc Trans Date: 2003-02 Impact factor: 5.407
Authors: D Stapleton; K I Mitchelhill; G Gao; J Widmer; B J Michell; T Teh; C M House; C S Fernandez; T Cox; L A Witters; B E Kemp Journal: J Biol Chem Date: 1996-01-12 Impact factor: 5.157
Authors: Eun-Kyoung Kim; Ian Miller; Susan Aja; Leslie E Landree; Michael Pinn; Jill McFadden; Francis P Kuhajda; Timothy H Moran; Gabriele V Ronnett Journal: J Biol Chem Date: 2004-03-17 Impact factor: 5.157
Authors: Feng Zhang; Suping Wang; Li Gan; Peter S Vosler; Yanqin Gao; Michael J Zigmond; Jun Chen Journal: Prog Neurobiol Date: 2011-09-10 Impact factor: 11.685
Authors: D Davila; N M C Connolly; H Bonner; P Weisová; H Dussmann; C G Concannon; H J Huber; J H M Prehn Journal: Cell Death Differ Date: 2012-04-27 Impact factor: 15.828